VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PPBT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PPBTPurple Biotech Ltd.
$1.74$8086
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPPBTQuarterly Financials

Purple Biotech Ltd. (PPBT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Purple Biotech Ltd. (PPBT) quarterly income statement — complete revenue, gross profit & net income history

PPBT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue000000000000
Revenue Growth %------------
Cost of Goods Sold64.82K53.33K58.27K48.01K44.77K40K49K0019600
COGS % of Revenue------------
Gross Profit-64.82K-53.33K-58.27K-48.01K-44.77K-40K-49K00-19600
Gross Margin %------------
Gross Profit Growth %-44.8%-33.33%-18.92%---20308.16%----63.33%--
Operating Expenses2.25M2.93M1.32M1.21M1.35M976K2.13M3.46M4.47M6.27M5.75M5.13M
OpEx % of Revenue------------
Selling, General & Admin1.02M1.09M725.39K649.66K597.88K310K785K865K1.04M829K1.16M1.43M
SG&A % of Revenue------------
Research & Development1.23M1.84M589.76K564.88K756.05K458K1.35M2.39M3.42M5.24M4.59M3.71M
R&D % of Revenue------------
Other Operating Expenses00011208K0202K0000
Operating Income-2.25M-2.98M-1.37M-1.26M-1.4M-1.02M-2.13M-3.46M-4.47M-6.27M-5.75M-5.13M
Operating Margin %------------
Operating Income Growth %-60.94%-193.46%35.61%63.49%68.68%83.79%62.89%32.66%12.81%5.06%-13.11%-243.04%
EBITDA-2.19M-2.93M-1.32M-1.21M-1.35M-976K-2.08M-3.41M-4.42M-6.22M-5.7M-5.08M
EBITDA Margin %------------
EBITDA Growth %-61.46%-200.02%36.89%64.37%69.35%84.31%63.42%32.92%12.96%5.07%-13.17%-239.54%
D&A (Non-Cash Add-back)65K53.33K58.27K48.01K44.77K40K49K49K48K48K50K53K
EBIT-58K-2.98M-1.37M-1.26M-1.4M-926K-157K-2.39M-3.76M-5.03M-5.04M-5.01M
Net Interest Income-11K-774.81K118.55K74.57K945.06K459.63K-381K97K78K-2.59M692K-25K
Interest Income20K197.22K123.58K74.57K979.88K459.63K130K121K95K0708K123K
Interest Expense31K972.03K5.02K034.82K0511K24K17K2.59M16K148K
Other Income/Expense2.16M-20.81M62.29K150.16K945.07K601K1.47M1.04M685K1.41M692K-25K
Pretax Income-89K-23.79M-1.31M-1.11M-453.63K-415K-668K-2.42M-3.78M-4.86M-5.05M-5.16M
Pretax Margin %------------
Income Tax000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-86K-23.69M-1.31M-1.11M-450.65K-410K-663K-2.4M-3.76M-4.83M-5.04M-5.14M
Net Margin %------------
Net Income Growth %80.92%-5678.55%-97.45%53.92%88.02%91.51%86.83%53.19%22.88%19.68%-4.39%-45.31%
Net Income (Continuing)-89K-23.79M-1.31M-1.11M-453.63K-415K-668K-2.42M-3.78M-4.86M-5.05M-5.16M
Discontinued Operations000000000000
Minority Interest-58K-55K42K44K48K51K56K61K71K90K121K140K
EPS (Diluted)-19.94-9870.00-40.00-4.00-1.80-2.00-3.80-17.40-27.80-37.80-46.20-49.00
EPS Growth %-1007.78%-493400%-952.63%77.01%93.53%94.71%91.77%64.49%43.5%42.2%13.48%-24.37%
EPS (Basic)-19.94-9870.00-40.00-4.00-1.80-2.00-3.80-17.40-27.80-37.40-46.20-49.00
Diluted Shares Outstanding4.65K2.4K284.7K273.62K263.23K205.13K173.26K137.66K135.57K128.95K109.18K105.03K
Basic Shares Outstanding4.65K2.4K284.7K273.71K263.37K205.21K173.29K137.66K135.57K127.89K109.18K105.03K
Dividend Payout Ratio------------